LETTER
Vancomycin-Resistant Staphylococcus aureus
Tammy Lundstrom, MD;
Judene Bartley, MS, MPH; and
Elaine Flanagan, RN, BSN
15 November 1996 | Volume 125 Issue 10 | Pages 858-859
TO THE EDITOR:
The article by Edmond and colleagues [1] on control of emergent vancomycin-resistant S. aureus is contrary to experience with the epidemiology and transmission of methicillin-resistant S. aureus. Little evidence supports airborne or fomite transmission of methicillin-resistant S. aureus. Acquired traits of antimicrobial resistance in bacteria have not been shown to alter virulence or transmission to the degree that could be inferred from the recommendations of Edmond and colleagues.
We advocate the use of broad universal precautions for all patients: hand washing before and after all patient contact; use of gloves for all contact with body fluids and secretions, mucous membranes, and nonintact skin; use of gowns if soiling is likely to occur; and use of masks and protective eye wear if splashing of body fluids is likely [2]. Use of broad universal precautions has many advantages, including 1) ease of implementation, 2) application of a single standard of care, 3) no reliance on identification of colonized or infected patients, 4) no reliance on routine culturing, 5) no need to flag charts for readmission, and 6) no need to isolate patients or staff. The use of broad universal precautions also protects workers from exposure to blood-borne pathogens.
We agree with Edmond and colleagues that hands are the major mode of transmission of methicillin-resistant S. aureus. Therefore, hand washing technique and compliance should be stressed. Use of mupirocin for eradicating nasal carriage of methicillin-resistant S. aureus has been shown to be effective in the short term. However, resistance and recolonization occur, limiting the usefulness of this agent to outbreaks. Cleaning of rooms with standard hospital-approved disinfectants eradicates resistant bacteria, but environmental cultures are costly, unnecessary, and contrary to recommendations of the Centers for Disease Control and Prevention. Specimen processing is unnecessary [3].
Efforts to control use of vancomycin should be the major focus of prevention strategies. Overuse of antimicrobial agents has consistently been shown to result in resistant organisms [4, 5]. Efforts should be focused on such measures of proven efficacy as hand washing and use of antibiotics.
|
Author and Article Information
|
|---|
Wayne State University, Detroit, MI 48201.
1. Edmond MB, Wenzel RP, Pasculle AW. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med. 1996; 124:329-34.
2. Management of methicillin-resistant Staphylococcus aureus (MRSA) in health care facilities. Michigan Society for Infection Control, Michigan Department of Public Health. 1991; 3:5-7.
3. Strain BA, Groschel DH. Laboratory safety and infectious waste management. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolker RH, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: American Society for Microbiology; 1995:75-85.
4. Murray BE. Can antibiotic resistance be controlled? N Engl J Med. 1994; 330:1229-30.
5. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1995; 16:105-13.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.